Association of long-term triglyceride-glucose index level and change with the risk of cardiometabolic diseases
- PMID: 37065738
- PMCID: PMC10098344
- DOI: 10.3389/fendo.2023.1148203
Association of long-term triglyceride-glucose index level and change with the risk of cardiometabolic diseases
Abstract
Objective: The triglyceride-glucose (TyG) index is considered as a pivotal factor for various metabolic, cardiovascular, and cerebrovascular diseases. However, there is currently a paucity of relevant studies on the association between long-term level and change of TyG-index and cardiometabolic diseases (CMDs) risk. We aimed to explore the risk of CMDs in relation to the long-term level and change of TyG-index.
Methods: Based on the prospective cohort study, a total of 36359 subjects who were free of CMDs, had complete data of triglyceride (TG) and fasting blood glucose (FBG) and underwent four health check-ups from 2006 to 2012 consecutively were followed up for CMDs until 2021. The associations between long-term level and change of TyG-index and CMDs risk were assessed by Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CIs). The TyG-index was calculated as ln [TG, mg/dL) × FBG, mg/dL)/2].
Results: During the median observation period of 8 years, 4685 subjects were newly diagnosed with CMDs. In multivariable-adjusted models, a graded positive association was observed between CMDs and long-term TyG-index. Compared with the Q1 group, subjects with the Q2-Q4 group had increased progressively risk of CMDs, with corresponding HRs of 1.64(1.47-1.83), 2.36(2.13-2.62), 3.15(2.84-3.49), respectively. The association was marginally attenuated, after further adjustment for the baseline TyG level. In addition, compared with stable TyG level, both loss and gain in TyG level were associated with increased CMDs risk.
Conclusions: Long-term elevated level and change of TyG-index are risk factors for the incident CMDs. Elevated TyG-index in the early stage remains to exert cumulative effects on the occurrence of CMDs even after accounting for the baseline TyG-index.
Keywords: cardiometabolic diseases; cohort study; cumulative effect; triglyceride-glucose index; triglyceride-glucose index change.
Copyright © 2023 Xu, Zhao, Gao, Guo, Liu, Li, Sun, Xing, Chen, Wu and Wu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study.Lancet Healthy Longev. 2023 Jan;4(1):e23-e33. doi: 10.1016/S2666-7568(22)00247-1. Epub 2022 Dec 12. Lancet Healthy Longev. 2023. PMID: 36521498
-
Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study.Cardiovasc Diabetol. 2021 May 26;20(1):113. doi: 10.1186/s12933-021-01305-7. Cardiovasc Diabetol. 2021. PMID: 34039351 Free PMC article.
-
Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study.Cardiovasc Diabetol. 2017 Mar 1;16(1):30. doi: 10.1186/s12933-017-0514-x. Cardiovasc Diabetol. 2017. PMID: 28249577 Free PMC article.
-
Danger-associated metabolites trigger metaflammation: A crowbar in cardiometabolic diseases.Pharmacol Res. 2023 Dec;198:106983. doi: 10.1016/j.phrs.2023.106983. Epub 2023 Nov 4. Pharmacol Res. 2023. PMID: 37931790 Review.
-
Novel Techniques, Biomarkers and Molecular Targets to Address Cardiometabolic Diseases.J Clin Med. 2024 May 14;13(10):2883. doi: 10.3390/jcm13102883. J Clin Med. 2024. PMID: 38792427 Free PMC article. Review.
Cited by
-
The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study.Cardiovasc Diabetol. 2024 Aug 31;23(1):321. doi: 10.1186/s12933-024-02387-9. Cardiovasc Diabetol. 2024. PMID: 39217401 Free PMC article.
-
Response: Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study (J Obes Metab Syndr 2022;31:178-86).J Obes Metab Syndr. 2023 Jun 30;32(2):181-182. doi: 10.7570/jomes23019. Epub 2023 Jun 14. J Obes Metab Syndr. 2023. PMID: 37311702 Free PMC article. No abstract available.
-
Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation.Cardiovasc Diabetol. 2025 Mar 10;24(1):112. doi: 10.1186/s12933-025-02651-6. Cardiovasc Diabetol. 2025. PMID: 40065358 Free PMC article.
-
Association of cumulative non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with the risk of cardiometabolic disease.Front Cardiovasc Med. 2024 Nov 20;11:1500025. doi: 10.3389/fcvm.2024.1500025. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39635266 Free PMC article.
-
Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis.Cardiovasc Diabetol. 2024 Oct 15;23(1):364. doi: 10.1186/s12933-024-02457-y. Cardiovasc Diabetol. 2024. PMID: 39407266 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous